Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €66.92 EUR
Change Today +0.82 / 1.24%
Volume 600.4K
UCB On Other Exchanges
Symbol
Exchange
EN Brussels
OTC US
As of 11:35 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for ucb sa (UCB)

Year over year, UCB S.A. has been able to grow revenues from €3.0B EUR to €3.1B EUR. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 33.58% to 31.60%. This was a driver that led to a bottom line growth from €160.0M EUR to €209.0M EUR.
View Income Statement In U.S. Dollar
Currency in
Millions of Euros
As of:Dec 31
2011
Restated
EUR
Dec 31
2012
Restated
EUR
Dec 31
2013
Restated
EUR
Dec 31
2014
EUR
4 Year
Trend
Revenues3,063.03,238.02,966.03,101.0
Other Revenues183.0224.0167.0243.0
TOTAL REVENUES3,246.03,462.03,133.03,344.0
Cost of Goods Sold1,013.01,084.0965.01,053.0
GROSS PROFIT2,233.02,378.02,168.02,291.0
Selling General & Admin Expenses, Total1,028.01,075.0996.0980.0
R&D Expenses778.0861.0886.0928.0
Other Operating Expenses-12.0-2.0-15.037.0
OTHER OPERATING EXPENSES, TOTAL1,794.01,934.01,867.01,945.0
OPERATING INCOME439.0444.0301.0346.0
Interest Expense-106.0-141.0-157.0-145.0
Interest and Investment Income8.016.037.050.0
NET INTEREST EXPENSE-98.0-125.0-120.0-95.0
Currency Exchange Gains (Loss)-9.0-6.014.0-13.0
Other Non-Operating Income (Expenses)-8.0-2.0-33.0-41.0
EBT, EXCLUDING UNUSUAL ITEMS324.0311.0162.0197.0
Merger & Restructuring Charges-27.0-40.0-32.0-63.0
Gain (Loss) on Sale of Investments---13.0-3.0-13.0
Gain (Loss) on Sale of Assets--31.023.020.0
Other Unusual Items, Total-64.0-26.0-29.0-30.0
Other Unusual Items-25.0-16.0----
EBT, INCLUDING UNUSUAL ITEMS233.0263.0121.0111.0
Income Tax Expense9.035.054.06.0
Minority Interest in Earnings--4.015.010.0
Earnings from Continuing Operations224.0228.067.0105.0
EARNINGS FROM DISCOUNTINUED OPERATIONS14.017.078.094.0
NET INCOME238.0249.0160.0209.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS238.0249.0160.0209.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS224.0232.082.0115.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UCB:BB €66.92 EUR +0.82

UCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Endo International PLC $83.71 USD -0.43
Grifols SA €36.03 EUR -0.23
Hospira Inc $88.50 USD +0.08
Lonza Group AG SFr.126.70 CHF -4.30
Sigma-Aldrich Corp $138.26 USD -0.89
View Industry Companies
 

Industry Analysis

UCB

Industry Average

Valuation UCB Industry Range
Price/Earnings 98.9x
Price/Sales 3.4x
Price/Book 2.3x
Price/Cash Flow 55.6x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UCB SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.